Black Kids Are 5 Times More Likely to Get Severe COVID. Now Vaccines Are Being Cut.
The Trump administration has declared an end to COVID-19 vaccine recommendations for children and pregnant people, and health experts have a warning: This is a threat to Black communities.
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., who oversees the Centers for Disease Control and Prevention, announced the decision on May 27 and said vaccine guidance would now focus solely on adults over 65 and those with high-risk conditions, effective immediately. By June 3, Dr. Lakshmi Panagiotakopoulos stepped down from her role helping lead the agency's COVID-19 vaccine advisory group, saying she could no longer support decisions that put pregnant people and children at risk.
Before the changes took effect, COVID-19 vaccines were recommended for anyone 6 months and older. Kennedy did not offer a scientific rationale for the new recommendations.
For Black Americans, the policy shifts are more than bureaucratic changes, according to Oni Blackstock, a physician and founder of Health Justice, a racial and health equity consulting practice.
'These new guidelines don't exist in a vacuum,' she said. 'Limiting booster eligibility risks further compromising the already fragile health status of many Black Americans.'
Black Americans are 1.5 times more likely to contract COVID-19 and four times more likely to be hospitalized, according to the Centers for Medicare & Medicaid Services. Research from the Center for Primary Care at Harvard Medical School found that Black children are more than five times as likely to die from the virus. An estimated 165,000 to 220,000 Black Americans have died from COVID-19, according to data compiled by the APM Research Lab.
According to a 2023 report from the U.S. Census Bureau, nearly 32% of Black Americans who contracted COVID-19 also experienced long COVID symptoms.
The U.S. Food and Drug Administration cited a lack of evidence that annual boosters are needed by healthy, low-risk adults. However, Blackstock, a primary care and HIV physician, said the policy change marks a significant departure from past years when vaccines were broadly recommended and federally funded.
'This contradicts recent CDC data showing that the 2024–2025 boosters benefit people 18 years and older, especially early after vaccination,' she added.
Blackstock noted that many Black Americans already struggle with health care access due to systemic barriers like a lack of insurance and residential segregation.
'When these combine with more restrictive vaccine guidelines,' she said, 'it becomes even harder for Black Americans to get boosters and worsens existing health disparities.'
These barriers also deepen historic mistrust in health care, said Jerry Abraham, a family and community medicine physician. Abraham, who is director of the CDU-KEDREN Mobile Street Medicine program in Los Angeles, said the history of medical racism and continued treatment disparities fuel skepticism toward public health. Even as boosters offer real benefits, he said, many remain hesitant or disconnected from resources that ensure protection.
'If children and pregnant women are no longer recommended for vaccination, will grandma still go to CVS and get it herself?' he said.
Abraham added that in an era where health care professionals can no longer trust the updated guidelines from federal agencies, it's deeply concerning and a reminder that Black communities must once again rely on themselves.
For answers about what comes next, read on.
Aisha Harris, a family medicine physician in Flint, Michigan, told Capital B that limiting access to COVID-19 vaccines for healthy adults exposes high-risk groups like seniors and those who are immunocompromised.
'Reduced protection in healthy people increases their risk of being infected by COVID and of being a carrier,' said Harris, who owns the direct primary care clinic Harris Family Medicine. 'When more people are contagious, with or without symptoms, they have a higher chance of infecting others around them, including in their household or those they are taking care of as caregivers.'
She warned this undermines community immunity. Without widespread coverage, even eligible groups face elevated risks.
FDA officials say the new approach mirrors those taken by Australia and several European nations that limit vaccines to older or high-risk adults. But some critics argue the shift ignores U.S. disparities and bypasses standard CDC procedures.
You can pay out of pocket, but it could cost up to $200. If the CDC doesn't recommend vaccines, Abraham said health plans are much less likely to cover them, since insurers typically follow CDC guidance.
Yes, COVID-19 vaccines have already undergone extensive clinical trials before being authorized for public use.
The FDA says it will require longer clinical trials before approving updated shots for healthy kids and adults, with studies lasting at least six months, likely delaying fall approvals.
The CDC's vaccine advisory committee is expected to vote on fall vaccine recommendations in late June, but it's unclear how much influence it will have over the newly announced changes.
High-risk conditions for COVID-19 vaccine eligibility generally include chronic kidney disease, chronic lung diseases, asthma, diabetes, immunocompromised states (from cancer treatment, organ transplant, HIV, etc.), heart conditions, Alzheimer's disease, obesity, sickle cell disease, smoking, and stroke or cerebrovascular disease.
Yes. Studies show COVID-19 vaccination, including boosters, reduces the risk of severe illness and may lower the chances of developing long COVID symptoms after infection.
The post Black Kids Are 5 Times More Likely to Get Severe COVID. Now Vaccines Are Being Cut. appeared first on Capital B News.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Can I donate blood and how do I do it? Urgent call for donors amid low stocks
The NHS needs 200,000 more regular blood donors to sustain a safe and sufficient supply. Low blood stocks in 2024 prompted an "amber alert', but blood stocks have remained low ever since. NHS Blood and Transplant (NHSBT) is now urging more people to donate to avoid a "red alert", which is a critical situation where public safety is threatened. It described the past year as "challenging" for blood stocks, noting that just under 800,000 people are supporting the entire blood supply in England. The whole process of giving blood takes just one hour. When arriving at a blood donation centre, you are asked to complete a safety check to make sure you can give blood. You will be given 500ml of fluid to drink – drinking this will help the body maintain blood pressure, prevent dizziness and help the body replenish the donated blood. Then, to ensure it is safe to donate blood, medics will confirm your identity and information in your health check. In some cases, a registered nurse will follow up. A drop of blood from your finger is then checked for iron levels. If these levels are too low, the appointment will be rescheduled. Those able to donate will be seated in the waiting area before being called to a donation chair. Here, a cuff will be placed on your arm to maintain a small amount of pressure during the donation before a suitable vein is found and the area is cleaned. Then, a needle will be inserted into your arm to collect your blood into a blood bag, which has your unique donor number on it. A scale weighs the blood and stops when you have donated 470ml - that's just under a pint. The needle is then removed from your arm, and a dressing is applied. The NHS says the process of giving blood should not hurt and should only take about 10 minutes. Although more donors are needed, there are some health, travel and lifestyle reasons that may stop you from donating blood. Donors need to be fit and well, aged between 17 and 65, weigh between 7 stone 12 Ibs (50kg) and 25 stone (158kg) and have suitable veins. However, you can't donate blood if you have cancer, some heart conditions, have tested positive for HIV or are a hepatitis B or C carrier. If you have received blood platelets, plasma or any other blood products after January 1980, or if you have injected non-prescribed drugs including body-building and injectable tanning agents, you also cannot donate. If you've had anal sex with a new partner in the last three months you may have to postpone your donation. If you feel unwell, are pregnant or have had a baby in the last six months, have had a tattoo or piercing, or have recently travelled to certain countries outside the UK, you may also have to wait before you can donate blood. There are thousands of blood donation venues across England, some are permanent and others are pop-ups. Church halls, sports centres, mosques, football stadiums and hotels are all used as pop-up venues. To check where your closest one is, visit the Give Blood website. You will need to book an appointment ahead of your donation which can be done online as soon as you have signed up as a blood donor. There is a 'critical' need for more donors who have the so-called universal blood type, O negative blood, which is needed for treatment in emergencies. The NHS said there is also a need for more Black donors, who are more likely to have specific blood types which can help treat people with sickle cell disease.
Yahoo
21 minutes ago
- Yahoo
NIH scientists condemn Trump research cuts
Hundreds of staffers from across the National Institutes of Health (NIH) are speaking out against the politicization of their research and termination of their work while demanding that the drastic changes made at the agency be walked back. In a letter addressed to NIH Director Jay Bhattacharya, more than 2,000 signatories stated, 'we dissent to Administration policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' The letter was titled 'The Bethesda Declaration' in reference to where NIH's campus is located. The signatories cited Bhattacharya's stated commitment to academic freedom that he made in April and called on him to push back against the changes Trump administration has implemented at NIH under his leadership. 'Academic freedom should not be applied selectively based on political ideology. To achieve political aims, NIH has targeted multiple universities with indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science,' they wrote. They pointed to U.S. law and prior research that has shown that the participation of diverse populations in studies is necessary for NIH's work. The NIH staffers further blasted the canceling of nearly completed studies. 'Ending a $5 million research study when it is 80% complete does not save $1 million, it wastes $4 million,' they wrote. The researchers called on Bhattacharya to restore foreign collaborations with the global scientific community, put independent peer reviews back in place, bring back terminated NIH staffers and rethink the 15 percent cap on indirect study costs that the Trump administration enacted. 'Combined, these actions have resulted in an unprecedented reduction in NIH spending that does not reflect efficiency but rather a dramatic reduction in life-saving research,' they stated. 'Some may use the false impression that NIH funding is not needed to justify the draconian cuts proposed in the President's Budget. This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research.' NIH research is not solely centered in Bethesda. The agency is responsible for funding research projects across the country and abroad. Numerous lawsuits have been filed to combat the pulling back of billions of dollars in NIH funding. Last week, a federal judge allowed a suit filed by university researchers and public health groups challenging the cuts to move forward. Bhattacharya responded to the letter on the social media platform X. 'We all want @NIH to succeed and I believe that dissent in science is productive. However, the Bethesda Declaration has some fundamental misconceptions about the policy directions NIH has taken in recent months,' he wrote. Bhattacharya said the actions taken at NIH have been to 'remove ideological influence from science' and further argued the agency hasn't halted international scientific collaboration but is instead 'ensuring accountability.' 'Claims that NIH is undermining peer review are misunderstood. We're expanding access to publishing while strengthening transparency, rigor, and reproducibility in NIH-funded research,' he wrote. 'Lastly, we are reviewing each termination case carefully and some individuals have already been reinstated. As NIH priorities evolve, so must our staffing to stay mission-focused and responsibly manage taxpayer dollars.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
30 minutes ago
- Yahoo
Why Universal Health Services (UHS) Shares Are Trading Lower Today
Shares of hospital management company Universal Health Services (NYSE:UHS) fell 5.7% in the afternoon session after Chief Financial Officer Steve Filton noted during a recent conference that procedural volumes (an important driver of hospital revenue) "have been slower to recover back to historical levels than we might have imagined." Filton also voiced concern over the Trump administration's proposed federal spending bill, particularly its implications for healthcare funding. Since UHS derives a significant portion of its revenue from government programs like Medicare and Medicaid, the anticipated cuts to Medicaid could significantly affect the company, especially in regions with high dependency on public healthcare funding. The shares closed the day at $177.76, down 6.2% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Universal Health Services? Access our full analysis report here, it's free. Universal Health Services's shares are not very volatile and have only had 8 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 28 days ago when the stock gained 5.9% after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels. Still, the agreement has cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueling renewed optimism. The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand. Universal Health Services is down 1.1% since the beginning of the year, and at $177.77 per share, it is trading 26.4% below its 52-week high of $241.52 from September 2024. Investors who bought $1,000 worth of Universal Health Services's shares 5 years ago would now be looking at an investment worth $1,628. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data